Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Neurology & psychiatryPRM 0129
Dosage formTablets
Oral

Amisulpride 100 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0130
Dosage formTablets
Oral

Amisulpride 100 mg (SR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0131
Dosage formTablets
Oral

Amisulpride 200 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0132
Dosage formTablets
Oral

Amisulpride 300 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0133
Dosage formTablets
Oral

Amisulpride 400 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 164
Neurology & psychiatryPRM 0134
Dosage formTablets
Oral

Amisulpride 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0204
Dosage formTablets
Oral

Asenapine Maleate 10 mg Sublingual

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 677
Neurology & psychiatryPRM 0205
Dosage formTablets
Oral

Asenapine Maleate 5 mg Sublingual

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 677
Neurology & psychiatryPRM 2200
Dosage formHard-gelatin capsules
Oral

Atomoxetine 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2201
Dosage formHard-gelatin capsules
Oral

Atomoxetine 18 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2202
Dosage formHard-gelatin capsules
Oral

Atomoxetine 25 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2203
Dosage formHard-gelatin capsules
Oral

Atomoxetine 40 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 671
Neurology & psychiatryPRM 2204
Dosage formHard-gelatin capsules
Oral

Atomoxetine 60 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 393
Neurology & psychiatryPRM 0233
Dosage formTablets
Oral

Baclofen 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 275
Neurology & psychiatryPRM 0234
Dosage formTablets
Oral

Baclofen 20 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0235
Dosage formTablets
Oral

Baclofen 25 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 275
Neurology & psychiatryPRM 0243
Dosage formTablets
Oral

Betahistine 16 mg Film Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 245
Neurology & psychiatryPRM 0244
Dosage formTablets
Oral

Betahistine 16 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 245
Neurology & psychiatryPRM 0246
Dosage formTablets
Oral

Betahistine 24 mg OD

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0245
Dosage formTablets
Oral

Betahistine 24 mg SR Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0241
Dosage formTablets
Oral

Betahistine 8 mg Fim Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0242
Dosage formTablets
Oral

Betahistine 8 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0265
Dosage formTablets
Oral

Blonanserin 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 82
Neurology & psychiatryPRM 0266
Dosage formTablets
Oral

Blonanserin 4 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
CNS agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 82

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product